/주식/FDMT
FDMT

FDMT

USD

4D Molecular Therapeutics Inc. Common Stock

$10.500-0.520 (-4.719%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$11.020

고가

$11.020

저가

$10.040

거래량

0.63M

기업 기본 정보

시가총액

578.4M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.80M

거래소

NMS

통화

USD

52주 범위

저가 $2.235현재가 $10.500고가 $12.34

관련 뉴스

GlobeNewswire

4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336

더 보기
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
Analyst Upgrades

RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target

RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.

더 보기
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
GlobeNewswire

4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference

EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with

더 보기
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference